Kewaunee Scientific (NASDAQ:KEQU) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen upgraded shares of Kewaunee Scientific (NASDAQ:KEQU - Free Report) from a hold rating to a buy rating in a report published on Saturday.

Kewaunee Scientific Price Performance

Shares of KEQU traded down $1.32 during mid-day trading on Friday, hitting $57.10. The company's stock had a trading volume of 8,550 shares, compared to its average volume of 23,031. The company has a debt-to-equity ratio of 0.92, a current ratio of 2.20 and a quick ratio of 1.59. The firm has a 50-day moving average price of $40.11 and a 200 day moving average price of $47.64. Kewaunee Scientific has a fifty-two week low of $30.33 and a fifty-two week high of $71.33. The stock has a market capitalization of $162.16 million, a price-to-earnings ratio of 14.91 and a beta of 0.70.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last posted its quarterly earnings results on Wednesday, June 25th. The technology company reported $1.95 earnings per share (EPS) for the quarter. Kewaunee Scientific had a net margin of 4.74% and a return on equity of 26.02%. The firm had revenue of $77.15 million for the quarter.

Insiders Place Their Bets

In other Kewaunee Scientific news, CEO Thomas David Hull III sold 1,844 shares of the company's stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $32.44, for a total transaction of $59,819.36. Following the completion of the sale, the chief executive officer directly owned 36,072 shares of the company's stock, valued at approximately $1,170,175.68. This represents a 4.86% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Donald T. Gardner III sold 3,000 shares of Kewaunee Scientific stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $37.75, for a total transaction of $113,250.00. Following the completion of the transaction, the chief financial officer directly owned 15,358 shares in the company, valued at approximately $579,764.50. This trade represents a 16.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. 14.20% of the stock is owned by insiders.

Institutional Investors Weigh In On Kewaunee Scientific

Several hedge funds have recently made changes to their positions in the company. IFP Advisors Inc lifted its holdings in shares of Kewaunee Scientific by 61.5% in the first quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock valued at $37,000 after purchasing an additional 360 shares in the last quarter. Bank of America Corp DE raised its position in Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock valued at $28,000 after buying an additional 443 shares during the period. O Shaughnessy Asset Management LLC lifted its stake in Kewaunee Scientific by 3.3% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company's stock worth $1,733,000 after acquiring an additional 891 shares in the last quarter. Jane Street Group LLC boosted its position in Kewaunee Scientific by 65.8% during the 1st quarter. Jane Street Group LLC now owns 8,052 shares of the technology company's stock worth $317,000 after acquiring an additional 3,196 shares during the period. Finally, Wedbush Securities Inc. acquired a new stake in Kewaunee Scientific during the 4th quarter worth about $262,000. Hedge funds and other institutional investors own 32.69% of the company's stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.